Overview

IcoSApent ethyL to Slow Down Aortic VAlve Stenosis proGrEssion

Status:
ACTIVE_NOT_RECRUITING
Trial end date:
2026-12-01
Target enrollment:
Participant gender:
Summary
This study invastigates the effect of icosapent ethyl in patients with aortic valve stenosis.
Phase:
PHASE2
Details
Lead Sponsor:
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Treatments:
eicosapentaenoic acid ethyl ester